mutLBSgeneDB |
Gene summary for MNAT1 |
Gene summary |
Basic gene Info. | Gene symbol | MNAT1 |
Gene name | MNAT CDK-activating kinase assembly factor 1 | |
Synonyms | CAP35|MAT1|RNF66|TFB3 | |
Cytomap | UCSC genome browser: 14q23 | |
Type of gene | protein-coding | |
RefGenes | NM_001177963.1, NM_002431.3, | |
Description | CDK-activating kinase assembly factor MAT1CDK7/cyclin-H assembly factorRING finger protein 66RING finger protein MAT1cyclin G1 interacting proteincyclin-G1-interacting proteinmenage a trois 1 (CAK assembly factor)menage a trois homolog 1, cyclin H | |
Modification date | 20141207 | |
dbXrefs | MIM : 602659 | |
HGNC : HGNC | ||
Ensembl : ENSG00000020426 | ||
HPRD : 04042 | ||
Vega : OTTHUMG00000152340 | ||
Protein | UniProt: P51948 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MNAT1 | |
BioGPS: 4331 | ||
Pathway | NCI Pathway Interaction Database: MNAT1 | |
KEGG: MNAT1 | ||
REACTOME: MNAT1 | ||
Pathway Commons: MNAT1 | ||
Context | iHOP: MNAT1 | |
ligand binding site mutation search in PubMed: MNAT1 | ||
UCL Cancer Institute: MNAT1 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006200 | ATP catabolic process | 9852112 | GO:0006357 | regulation of transcription from RNA polymerase II promoter | 10801852 | GO:0006366 | transcription from RNA polymerase II promoter | 9852112 | GO:0006468 | protein phosphorylation | 9852112 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8692841 |
Top |
Ligand binding site mutations for MNAT1 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | C31 | L30F | HNSC | 1 | C9 | R8W | HNSC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for MNAT1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C31 | L30F | -1.0362268 | C9 | R8W | -0.75155062 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for MNAT1 from PDB |
Top |
Differential gene expression and gene-gene network for MNAT1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for MNAT1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for MNAT1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of MNAT1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 1g25 | A | C9 C31 |
Top |
Conservation information for LBS of MNAT1 |
Multiple alignments for P51948 in multiple species |
LBS | AA sequence | # species | Species | C26 | MVNV-CGHTLC | 2 | Homo sapiens, Mus musculus | C26 | LINPECYHKMC | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C26 | LVNPECYHRIC | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | C26 | LINPECYHKIC | 1 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | C26 | LVNPECYHKIC | 1 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C31 | CGHTLCESCVD | 2 | Homo sapiens, Mus musculus | C31 | CYHKICESCVD | 2 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C31 | CYHKMCESCVD | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C31 | CYHRICESCVD | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | C34 | TLCESCVDLLF | 2 | Homo sapiens, Mus musculus | C34 | KICESCVDRIF | 2 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C34 | KMCESCVDRIF | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C34 | RICESCVDRIF | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | C46 | RGAGNCP--EC | 2 | Homo sapiens, Mus musculus | C46 | LGPAQCPYEGC | 2 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C46 | TGPAQCPTPGC | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C46 | LGPAQCPYKGC | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | C49 | CP--ECGTPLR | 2 | Homo sapiens, Mus musculus | C49 | CPYEGCDKILR | 2 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C49 | CPTPGCNKILR | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C49 | CPYKGCDKILR | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | C6 | DM---CPICKT | 3 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C6 | -----CPRCKT | 2 | Homo sapiens, Mus musculus | C6 | KVDEKCPLCQA | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | C9 | --CPICKTDRY | 3 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | C9 | --CPRCKTTKY | 2 | Homo sapiens, Mus musculus | C9 | EKCPLCQADRY | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | H28 | NV-CGHTLCES | 2 | Homo sapiens, Mus musculus | H28 | NPECYHKICES | 2 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | H28 | NPECYHKMCES | 1 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | H28 | NPECYHRICES | 1 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |